Predictors of microvascular complications in type 1 diabetic patients at onset: The role of metabolic memory

被引:20
作者
Giordano, Carla [1 ]
Amato, Marco Calogero [1 ]
Ciresi, Alessandro [1 ]
Citarrella, Roberto [1 ]
Mantione, Lucilla [1 ]
Accidenti, Maria [1 ]
Panto, Felicia [1 ]
Guarnotta, Valentina [1 ]
Allotta, Maria Luisa [1 ]
Criscimanna, Angela [1 ]
Galluzzo, Aldo [1 ]
机构
[1] Univ Palermo, Endocrinol Sect, Ctr Riferimento Reg Diag & Cura Endocrinopatie Au, Dipartimento Med Interna & Med Sperimentale DIBIM, I-90127 Palermo, Italy
关键词
Type; 1; diabetes; Metabolic memory; HbA1c levels; Nephropathy; Retinopathy; Microalbuminuria; BETA-CELL FUNCTION; GLYCEMIC CONTROL; INSULIN-SECRETION; C-PEPTIDE; RETINOPATHY; MICROALBUMINURIA; RISK; NEPHROPATHY; PROGRESSION; GLUCOSE;
D O I
10.1016/j.ejim.2011.02.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Several epidemiological studies showed a close association between metabolic control and microvascular complications in type 1 Diabetes Mellitus (T1DM). The aim of our longitudinal observational study was to evaluate the predictive role of the main clinical and biochemical parameters in determining microvascular complications. Methods: 376 T1DM patients, hospitalized in our division from 1991 to 2005 (mean follow-up = 10.93 +/- 4.26 years) were studied. Stepwise Cox regression analysis was used to identify the influence of residual beta-cell function, beta-cell autoimmunity, HbA1c levels and other clinical and laboratory parameters in the development of microalbuminuria and retinopathy. Results: The probability of developing microalbuminuria was higher in males than in females (HR 1.82; 95% CI 1.01-3.28; p = 0.044), in patients with higher mean HbA1c values (HR 2.80; 95% CI 1.63-4.83; p < 0.001), longer duration of disease (HR 1.98; 95% CI 1.10-3.57; p = 0.022) and younger age of diabetes onset (HR 0.53; 95% CI 0.03-0.92; p = 0.026). An increased probability of developing retinopathy was found in patients with higher mean HbA1c levels during follow-up (HR 2.35; 95% CI 1.34-4.12, p = 0.003), as well as at onset (HR 1.85; 95% CI 1.06-3.24; p = 0.030). Conclusions: Our study suggests that among the clinical, metabolic, immunological and biochemical factors evaluated at onset, only HbA1c is predictive for the microangiopathy development in T1DM. (C) 2011 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:266 / 274
页数:9
相关论文
共 51 条
  • [21] A NATIONWIDE CROSS-SECTIONAL STUDY OF RETINOPATHY AND MICROALBUMINURIA IN YOUNG NORWEGIAN TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS
    JONER, G
    BRINCHMANNHANSEN, O
    TORRES, CG
    HANSSEN, KF
    [J]. DIABETOLOGIA, 1992, 35 (11) : 1049 - 1054
  • [22] Residual Insulin Production and Pancreatic β-Cell Turnover After 50 Years of Diabetes: Joslin Medalist Study
    Keenan, Hillary A.
    Sun, Jennifer K.
    Levine, Jared
    Doria, Alessandro
    Aiello, Lloyd P.
    Eisenbarth, George
    Bonner-Weir, Susan
    King, George L.
    [J]. DIABETES, 2010, 59 (11) : 2846 - 2853
  • [23] The effect of glucose variability on the risk of microvascular complications in type 1 diabetes
    Kilpatrick, Eric S.
    Rigby, Alan S.
    Atkin, Stephen L.
    [J]. DIABETES CARE, 2006, 29 (07) : 1486 - 1490
  • [24] THE WISCONSIN EPIDEMIOLOGIC-STUDY OF DIABETIC-RETINOPATHY .9. 4-YEAR INCIDENCE AND PROGRESSION OF DIABETIC-RETINOPATHY WHEN AGE AT DIAGNOSIS IS LESS THAN 30 YEARS
    KLEIN, R
    KLEIN, BEK
    MOSS, SE
    DAVIS, MD
    DEMETS, DL
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1989, 107 (02) : 237 - 243
  • [25] Autoimmune mechanisms in type 1 diabetes
    Knip, Mikael
    Siljander, Heli
    [J]. AUTOIMMUNITY REVIEWS, 2008, 7 (07) : 550 - 557
  • [26] PREDISPOSITION TO HYPERTENSION AND SUSCEPTIBILITY TO RENAL-DISEASE IN INSULIN-DEPENDENT DIABETES-MELLITUS
    KROLEWSKI, AS
    CANESSA, M
    WARRAM, JH
    LAFFEL, LMB
    CHRISTLIEB, AR
    KNOWLER, WC
    RAND, LI
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (03) : 140 - 145
  • [27] BASE-LINE ANALYSIS OF RENAL-FUNCTION IN THE DIABETES CONTROL AND COMPLICATIONS TRIAL
    MOLITCH, ME
    STEFFES, MW
    CLEARY, PA
    NATHAN, DM
    [J]. KIDNEY INTERNATIONAL, 1993, 43 (03) : 668 - 674
  • [28] Familial risk factors for microvascular complications and differential male-female risk in a large cohort of American families with type 1 diabetes
    Monti, Maria C.
    Lonsdale, John T.
    Montomoli, Cristina
    Montross, Rebecca
    Schlag, Erin
    Greenberg, David A.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (12) : 4650 - 4655
  • [29] RESIDUAL BETA-CELL FUNCTION AND HLA-A24 IN IDDM - MARKERS OF GLYCEMIC CONTROL AND SUBSEQUENT DEVELOPMENT OF DIABETIC-RETINOPATHY
    NAKANISHI, K
    KOBAYASHI, T
    INOKO, H
    TSUJI, K
    MURASE, T
    KOSAKA, K
    [J]. DIABETES, 1995, 44 (11) : 1334 - 1339
  • [30] International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes
    Nathan, David M.
    Nathan, David M.
    Balkau, Beverly
    Bonora, Enzo
    Borch-Johnsen, Knut
    Buse, John B.
    Colagiuri, Stephen
    Davidson, Mayer B.
    DeFronzo, Ralph
    Genuth, Saul
    Holman, Rury R.
    Ji, Linong
    Kirkman, Sue
    Knowler, William C.
    Schatz, Desmond
    Shaw, Jonathan
    Sobngwi, Eugene
    Steffes, Michael
    Vaccaro, Olga
    Wareham, Nick
    Zinman, Bernard
    Kahn, Richard
    [J]. DIABETES CARE, 2009, 32 (07) : 1327 - 1334